| Patents for C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967) |
|---|
| 06/08/2006 | US20060120991 N-halamine vinyl compounds and their polymeric biocides |
| 06/07/2006 | EP1664031A2 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors |
| 06/07/2006 | EP1406878B1 4-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1, 2, 4) triazin-5-one derivatives having a pde-iv inhibiting and tnf-antagonistic effect for the treatment of cardiac diseases and allergies |
| 06/07/2006 | EP1345939B1 Method for producing sulfonamide-substituted imidazotriazinones |
| 06/06/2006 | CA2154572C Use of riluzole for the treatment of neuro-sida |
| 06/01/2006 | US20060115865 Lamotrigine analogs |
| 05/30/2006 | CA2321380C 6-azauracil derivatives as thyroid receptor ligands |
| 05/24/2006 | EP1363912B1 Substituted imidazotriazinones |
| 05/16/2006 | US7045660 [di(ether or thioether)heteroaryl or fluoro substituted aryl] compound or an N-oxide thereof or a salt thereof, useful for inhibiting the production or physiological effects of TNF in treatment of a patient suffering from a disease state associated with a detrimental excess of tumor necrosis factor |
| 05/10/2006 | CN1771234A Process for preparing pyrrolotriazine kinase inhibitors |
| 05/09/2006 | US7041670 Florfenicol-type antibiotics |
| 05/04/2006 | WO2006047451A2 Immunoassays for lamotrigine |
| 05/04/2006 | WO2006047372A2 Lamotrigine analogs |
| 05/04/2006 | WO2005025681A3 A system for and a method of manufacturing personal golf putters |
| 05/04/2006 | CA2586474A1 Lamotrigine analogs |
| 05/03/2006 | EP1651229A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists |
| 05/03/2006 | CN1768038A Using alkylmetal reagents for directed metalation of azaaromatics |
| 05/02/2006 | US7037930 3-arylphenyl sulfide derivative and insecticide and miticide |
| 04/26/2006 | EP1153922B1 Heterodiazinone derivatives |
| 04/25/2006 | US7034151 1,4-dihydro-4-oxo-pyrrolo[2,1-f][1,2,4]triazine-6-carboxylates; novel approach to the formation of the bicyclic heterocyclic ring system |
| 04/25/2006 | US7034035 Having a high residual activity, greater activity at lower application rates, curative activity, and a broader spectrum of efficacy; heterocyclic aromatic amides having a hydroxy group adjacent to the amide functionality |
| 04/25/2006 | US7034033 Substituted quinazolinone compounds |
| 04/20/2006 | US20060084809 Compounds as PDE IV and TNF-inhibitors |
| 04/18/2006 | US7030117 Sodium channel blockers |
| 04/13/2006 | WO2006003500A8 Method for preparing 5-`4-(2-hydroxy-propyl)-3,5-dioxo-4,5-dihydro-3h`1,2,4!triazin-2-yl!-benzamide derivatives by deprotecting the hydroxyl-protected precursers |
| 04/13/2006 | US20060079526 Heterocyclic compounds and methods of use |
| 04/12/2006 | CN1250223C Pyrrolo-triazine and pyrimidine compounds |
| 03/23/2006 | US20060063765 5-[({[({(2S)-4-[(3,4-dichlorophenyl)methyl]-2-morpholinyl}methyl)amino]carbonyl}amino)methyl]-N-methyl-3-furancarboxamide; free of N-{[4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}-N'-(2-furylmethyl)urea; CCR3/chemokine recetptor/ antagonists |
| 03/23/2006 | DE19638886B4 Selektive Herbizide auf Basis von Metribuzin und substituierten Imidazo [1,2-a]pyridin-3-yl-sulfonylverbindungen Selective herbicides based on metribuzin and substituted imidazo [1,2-a] pyridin-3-yl-sulfonyl |
| 03/22/2006 | CN1751024A Nitrogenous heterocyclic derivative and organic electroluminescent element employing the same |
| 03/21/2006 | US7015230 serine protease inhibitors comprising pyrimidinediones, used as anticoagulants for prophylaxis of cardiovascular disorders; thrombolytic agents |
| 03/21/2006 | US7015223 Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade |
| 03/21/2006 | CA2238092C Process for preparing 3-amino-1,2,4-benzotriazine dioxide |
| 03/16/2006 | US20060058302 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases; example compound: 2-Chloro-5-(3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(2-ethyl-hexyl)-benzamide |
| 03/15/2006 | EP1633723A1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4) |
| 03/15/2006 | EP1608634A4 Methods for isolating crystalline form i of 5-azacytidine |
| 03/15/2006 | CN1747941A HIV inhibiting 1,2,4-triazines |
| 03/15/2006 | CN1245391C Pyrimidine, Triazine and pyrazine derivatives as glutamate receptors |
| 03/09/2006 | US20060052625 Reaction of 2,3-dichlorobenzoyl cyanide with aminoguanidine bicarbonate in non-aqueous medium in the presence of methanesulphonic acid to form intermediate 2-(2,3-dichlorophenyl)-2-(aminoguanidine)acetonitrile, cyclizing the intermediate to form 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine |
| 03/09/2006 | DE10231627B4 Heterozyklisch substituierte Benzoylharnstoffe und ihre Verwendung als Arzneimittel Heterocyclic unsubstituted benzoyl ureas and their use as a medicament |
| 03/02/2006 | CA2578283A1 Heterocyclic compounds and methods of use |
| 03/01/2006 | EP1363910B1 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 02/23/2006 | US20060041124 Process for preparing pyrrolotriazine kinase inhibitors |
| 02/23/2006 | US20060040942 Antiinflammatory agents; autoimmune disease |
| 02/23/2006 | US20060040941 7-Aminoimidazotriazones |
| 02/23/2006 | US20060040939 Benzamide inhibitors of the P2X, receptor |
| 02/16/2006 | CA2575002A1 Hiv inhibiting 1,2,4-triazin-6-one derivatives |
| 02/15/2006 | CN1733742A Phentriazine derivative preparation and uses |
| 02/14/2006 | US6998402 7-(1-Acetylpentyl)-5-methyl-2-(4-methylbenzyl)imidazo[5,1-f][1,2,4]triazin-4(3H)-one; learning enhancement, concentration power, learning power, memory power; enzyme inhibitors of phosphodiesterase isoenzyme |
| 02/09/2006 | US20060030573 melanocortin-4 receptor (MC4-R) agonists such as (3R,5S)-N-(2-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-1-oxo-1,2-dihydroisoquinolin-6-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used for the treatment of obesity or diabetes |
| 02/09/2006 | US20060030553 Cell adhesion inhibitors |
| 02/08/2006 | CN1732006A 3-(3,5-dioxo-4,5-dihydro-3h-(1,2,4)triazin-2-yl)-benzamide derivatives as P2X7-inhibitors for the treatment of inflammatory diseases |
| 02/07/2006 | US6995157 Substituted 4,5-dihydro-1,2,4-triazin-3-ones, 1,2,4-triazin-3-ones, and their use as fungicides and insecticides |
| 02/02/2006 | US20060025416 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/01/2006 | EP1620411A2 Inhibitors of akt activity |
| 01/19/2006 | US20060014743 Methods of preventing bacterial infections with florfenicol-type antibiotics |
| 01/18/2006 | CN1237051C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/12/2006 | WO2006003513A1 Method for preparing 5-`4-(2-hydroxy-ethyl)-3,5-dioxo-4,5-dihydro-3h-`1,2,4!-triazin-2-yl!benzamide derivatives with p2x7 inhibiting activity by reaction of the derivative unsubstituted in 4-position of the triazine with an oxiran in the presence of a lewis acid |
| 01/12/2006 | WO2006003500A1 Method for preparing 5-`4-(2-hydroxy-propyl)-3,5-dioxo-4,5-dihydro-3h`1,2,4!triazin-2-yl!-benzamide derivatives by deprotecting the hydroxyl-protected precursers |
| 01/12/2006 | CA2572118A1 Method for preparing 5-`4-(2-hydroxy-ethyl)-3,5-dioxo-4,5-dihydro-3h-`1,2,4!-triazin-2-yl!benzamide derivatives with p2x7 inhibiting activity by reaction of the derivative unsubstituted in 4-position of the triazine with an oxiran in the presence of a lewis acid |
| 01/12/2006 | CA2571124A1 Method for preparing 5-`4-(2-hydroxy-propyl)-3,5-dioxo-4,5-dihydro-3h`1,2,4!triazin-2-yl!-benzamide derivatives by deprotecting the hydroxyl-protected precursers |
| 01/11/2006 | CN1720224A Vasculostatic agents and methods of use thereof |
| 01/04/2006 | EP1611102A2 Using alkylmetal reagents for directed metalation of azaaromatics |
| 12/29/2005 | US20050288288 Methods for preparing P2X7 inhibitors |
| 12/29/2005 | US20050288256 Methods for preparing P2X7 inhibitors |
| 12/28/2005 | EP1608634A2 Methods for isolating crystalline form i of 5-azacytidine |
| 12/27/2005 | CA2305463C Aminobutanoic acid derivatives |
| 12/22/2005 | WO2005121128A1 5,6-diphenyl-1,2,4-triazinic dimeric derivatives and the use thereof in the form of sun-protective agents |
| 12/22/2005 | WO2005121108A1 Monomer 5,6-diphenyl-1,2,4-triazinic derivatives and the use thereof |
| 12/22/2005 | US20050282814 Vasculostatic agents and methods of use thereof |
| 12/14/2005 | EP1603889A1 Novel crystalline forms of lamotrigine |
| 12/13/2005 | US6974812 such as 2-chloro-N-(1-hydroxy-cycloheptylmethyl)-5-[4-(2-hydroxy-3-methoxy-propyl)-3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl]-benzamide; purinergic receptors (P2x7 E); for treatment of interleukin-1 associated disorders (rheumatoid arthritis) |
| 12/08/2005 | WO2005115992A1 Theramutein modulators |
| 12/08/2005 | US20050272732 5-ethyl-imidazo (5,1-F) (1,2,4,) triazin-4 (3h)-ones as phosphodiesterase inhibitors |
| 12/08/2005 | US20050272675 Methods for isolating crystalline form I of 5-azacytidine |
| 12/08/2005 | DE3745196B4 1,2,4-Benzotriazine oxide derivs. - used for radio-sensitising hypoxic tumour cells and selectively killing hypoxic tumour cells |
| 12/08/2005 | CA2567813A1 Theramutein modulators |
| 12/07/2005 | EP1175410B1 Pesticidal triazine derivatives |
| 12/01/2005 | US20050267123 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 12/01/2005 | US20050267102 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids |
| 11/30/2005 | EP1599096A2 Hetero substitued sodium channel blockers |
| 11/29/2005 | US6969715 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 11/24/2005 | US20050261503 Heteroaromatic glucokinase activators |
| 11/23/2005 | EP1597242A1 Hiv inhibiting 1,2,4-triazines |
| 11/17/2005 | WO2005108368A1 Adamantyl-acetamide derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 11/17/2005 | WO2005072361A3 Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity |
| 11/17/2005 | WO2005023204A3 Aromatic prodrugs of propofol, compositions and uses thereof |
| 11/17/2005 | CA2568241A1 Adamantyl-acetamide derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 11/16/2005 | CN1227234C Substituted iminoazines |
| 11/03/2005 | US20050245534 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
| 11/03/2005 | US20050245525 Compounds useful for inhibiting CHK1 |
| 11/02/2005 | EP1590335A2 Process for preparing pyrrolotriazine kinase inhibitors |
| 11/02/2005 | CN1692109A Novel compounds as NS3-serine protease inhibitors of hepatitis c virus |
| 10/27/2005 | US20050239860 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 10/20/2005 | CA2567574A1 Benzotriazine inhibitors of kinases |
| 10/19/2005 | EP1585733A1 Heterocyclic ppar modulators |
| 10/13/2005 | WO2005021536A3 Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors |
| 10/12/2005 | EP1583746A1 A pyrazole derivative as ppar modulator |
| 10/11/2005 | US6953852 by reacting benzofuroxan with cyanamide within non-aqueous solvents; exothermic reaction temperature controlled by cooling; industrial scale with high purity and yield; avoids use of dimethyl sulfoxide and methanesulfonic acid |
| 10/06/2005 | US20050222412 Antibiotic; bactericides |